HepaTx Corporation
PrivateLast Round
Grant
May 20, 2025
Est. Valuation
$2.14M
Total Funding Raised
$550,988
Company Overview
HepaTx Corporation is a clinical-stage biotechnology company that specializes in regenerative medicine. It is focused on developing stem cell-based therapies as an alternative to liver transplants for patients with late-stage liver disease. The company's proprietary technology, anchored in work from Stanford University, aims to enable the efficient production of hepatocytes for therapeutic purposes, which can replace lost liver function. A recent collaboration with the Mayo Clinic, announced in September 2024, is intended to accelerate the development of its cell therapy technology into clinical trials, with an initial focus on alcohol-related hepatitis. The company's mission is to provide a scalable and cost-effective treatment to address the significant unmet need for patients with life-threatening liver conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HepaTx Corporation Comps
Public and private peers based on sector, stage, and business model.
HepaTx Corporation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 20, 2025 | ||||
| Grant | Sep 1, 2019 | ||||
| Seed | Aug 21, 2018 |
HepaTx Corporation Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| Y Combinator | Seed |
HepaTx Corporation Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about HepaTx Corporation's valuation, stock price, and market status.
